Amdocs [DOX] vs Klaviyo [KVYO] Detailed Stock Comparison
Amdocs
NASDAQ
Loading...
Klaviyo
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 18 vital metrics comparison: Amdocs wins in 13 metrics, Klaviyo wins in 4 metrics, with 0 ties. Amdocs appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Amdocs | Klaviyo | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 18.68 | -189.26 | Klaviyo |
| Price-to-Book Ratio | 2.81 | 8.98 | Amdocs |
| Debt-to-Equity Ratio | 23.65 | 9.65 | Klaviyo |
| PEG Ratio | 12.65 | 60.77 | Amdocs |
| EV/EBITDA | 9.96 | -123.22 | Klaviyo |
| Profit Margin (TTM) | 11.94% | -4.70% | Amdocs |
| Operating Margin (TTM) | 17.69% | -8.49% | Amdocs |
| EBITDA Margin (TTM) | 17.69% | N/A | N/A |
| Return on Equity | 15.73% | -4.73% | Amdocs |
| Return on Assets (TTM) | 7.87% | -4.36% | Amdocs |
| Free Cash Flow (TTM) | $618.93M | $148.73M | Amdocs |
| 1-Year Return | 7.71% | 3.92% | Amdocs |
| Price-to-Sales Ratio (TTM) | 2.13 | 10.52 | Amdocs |
| Enterprise Value | $9.89B | $8.96B | Amdocs |
| EV/Revenue Ratio | 2.13 | 8.90 | Amdocs |
| Gross Profit Margin (TTM) | 38.13% | 75.70% | Klaviyo |
| Revenue per Share (TTM) | $41 | $4 | Amdocs |
| Earnings per Share (Diluted) | $4.76 | $-0.23 | Amdocs |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Amdocs vs Klaviyo Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Amdocs | 0.61% | 5.82% | -3.47% | -3.39% | 4.21% | 6.24% |
| Klaviyo | -4.94% | 8.85% | -4.74% | -2.68% | -34.23% | -22.31% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Amdocs | 7.71% | 0.53% | 44.69% | 48.02% | 241.04% | 197.77% |
| Klaviyo | 3.92% | -3.23% | -3.23% | -3.23% | -3.23% | -3.23% |
Performance & Financial Health Analysis: Amdocs vs Klaviyo
| Metric | DOX | KVYO |
|---|---|---|
| Market Information | ||
| Market Cap | $9.89B | $10.59B |
| Market Cap Category | Mid cap | Large cap |
| 10 Day Avg. Volume | 697,190 | 2,787,202 |
| 90 Day Avg. Volume | 727,940 | 1,659,394 |
| Last Close | $89.41 | $32.35 |
| 52 Week Range | $78.61 - $95.41 | $23.77 - $49.55 |
| % from 52W High | -6.29% | -34.71% |
| All-Time High | $99.75 (Jun 26, 2023) | $49.55 (Feb 10, 2025) |
| % from All-Time High | -10.37% | -34.71% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.08% | 0.33% |
| Quarterly Earnings Growth | 0.10% | 0.32% |
| Financial Health | ||
| Profit Margin (TTM) | 0.12% | -0.05% |
| Operating Margin (TTM) | 0.18% | -0.08% |
| Return on Equity (TTM) | 0.16% | -0.05% |
| Debt to Equity (MRQ) | 23.65 | 9.65 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $31.67 | $3.79 |
| Cash per Share (MRQ) | $3.10 | $3.22 |
| Operating Cash Flow (TTM) | $737.18M | $154.14M |
| Levered Free Cash Flow (TTM) | $560.12M | $166.37M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Amdocs vs Klaviyo
| Metric | DOX | KVYO |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 18.68 | -189.26 |
| Forward P/E | 12.65 | 60.77 |
| PEG Ratio | 12.65 | 60.77 |
| Price to Sales (TTM) | 2.13 | 10.52 |
| Price to Book (MRQ) | 2.81 | 8.98 |
| Market Capitalization | ||
| Market Capitalization | $9.89B | $10.59B |
| Enterprise Value | $9.89B | $8.96B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 2.13 | 8.90 |
| Enterprise to EBITDA | 9.96 | -123.22 |
| Risk & Other Metrics | ||
| Beta | N/A | N/A |
| Book Value per Share (MRQ) | $31.67 | $3.79 |
Financial Statements Comparison: Amdocs vs Klaviyo
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | DOX | KVYO |
|---|---|---|
| Revenue/Sales | $1.13B | $293.12M |
| Cost of Goods Sold | $698.05M | $71.24M |
| Gross Profit | $430.15M | $221.88M |
| Research & Development | $81.80M | $72.46M |
| Operating Income (EBIT) | $197.74M | $-31.33M |
| EBITDA | $244.14M | $-27.40M |
| Pre-Tax Income | $189.27M | $-22.48M |
| Income Tax | $25.27M | $1.80M |
| Net Income (Profit) | $164.00M | $-24.28M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | DOX | KVYO |
|---|---|---|
| Cash & Equivalents | $247.39M | $888.43M |
| Total Current Assets | $1.56B | $1.01B |
| Total Current Liabilities | $1.34B | $192.82M |
| Long-Term Debt | $748.93M | $84.12M |
| Total Shareholders Equity | $3.50B | $1.06B |
| Retained Earnings | N/A | $-859.27M |
| Property, Plant & Equipment | $874.85M | $90.82M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | DOX | KVYO |
|---|---|---|
| Operating Cash Flow | $195.07M | $36.85M |
| Capital Expenditures | $-15.96M | $-2.69M |
| Free Cash Flow | $156.49M | $6.62M |
| Debt Repayment | N/A | $0 |
| Common Stock Repurchase | $-135.24M | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | DOX | KVYO |
|---|---|---|
| Shares Short | 3.93M | 5.64M |
| Short Ratio | 5.04 | 4.03 |
| Short % of Float | 0.04% | 0.05% |
| Average Daily Volume (10 Day) | 697,190 | 2,787,202 |
| Average Daily Volume (90 Day) | 727,940 | 1,659,394 |
| Shares Outstanding | 112.89M | 272.76M |
| Float Shares | 108.54M | 94.16M |
| % Held by Insiders | 0.00% | 0.00% |
| % Held by Institutions | 1.00% | 0.94% |
Dividend Analysis & Yield Comparison: Amdocs vs Klaviyo
| Metric | DOX | KVYO |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |